Gender difference in hematological toxicity among lung cancer patients receiving amrubicin monotherapy.

MLA

Makihara, Reiko Ando, et al. “Gender Difference in Hematological Toxicity among Lung Cancer Patients Receiving Amrubicin Monotherapy.” Japanese Journal of Clinical Oncology, vol. 42, no. 12, Dec. 2012, pp. 1187–91. EBSCOhost, https://doi.org/10.1093/jjco/hys170.

APA

Makihara, R. A., Makino, Y., Yamamoto, N., Yokote, N., Nokihara, H., Sekine, I., Ohe, Y., Tamura, T., & Yamamoto, H. (2012). Gender difference in hematological toxicity among lung cancer patients receiving amrubicin monotherapy. Japanese Journal of Clinical Oncology, 42(12), 1187–1191. https://doi.org/10.1093/jjco/hys170

Chicago

Makihara, Reiko Ando, Yoshinori Makino, Noboru Yamamoto, Nobuaki Yokote, Hiroshi Nokihara, Ikuo Sekine, Yuichiro Ohe, Tomohide Tamura, and Hiroshi Yamamoto. 2012. “Gender Difference in Hematological Toxicity among Lung Cancer Patients Receiving Amrubicin Monotherapy.” Japanese Journal of Clinical Oncology 42 (12): 1187–91. doi:10.1093/jjco/hys170.